Literature DB >> 26731563

Ovarian cancer: epidemiology and risk factors.

Carlo La Vecchia1.   

Abstract

The present overview of ovarian cancer epidemiology summarizes the main results for a network of case-control studies in Italy and from the Collaborative Group on Epidemiological Studies of Ovarian Cancer. There are consistent inverse relations between parity, oral contraceptive use and the risk of ovarian cancer. For other menstrual and hormonal factors (i.e. early age at menarche and late menopause), there are established associations, but of limited impact on ovarian cancer incidence on a population level. Serous and endometrioid ovarian cancers (but not mucinous or clear cell types) are related to current and recent use of hormone replacement therapy in menopause. There are no strong associations with alcohol and tobacco overall, but a direct link for tobacco with (borderline) mucinous cancers, of limited impact, however, on overall ovarian cancer mortality. There are direct associations of ovarian cancer risk with height and BMI, as well as possible relations with selected dietary factors - in the absence, however, of consistent findings - and a possible inverse association with physical activity. There is a strong association with a family history of ovarian cancer (and a few selected other neoplasms, including colorectum and endometrium). Recognized risk factors explain only a limited proportion of ovarian cancer cases on a population level. A key reason for the recent favourable trends of ovarian cancer incidence and mortality in several high-income countries is the widespread use of oral contraceptive in the generations born after 1930.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 26731563     DOI: 10.1097/CEJ.0000000000000217

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  64 in total

1.  Mortality by occupation-based social class in Italy from 2012 to 2014.

Authors:  Paola Bertuccio; Gianfranco Alicandro; Gabriella Sebastiani; Nicolas Zengarini; Giuseppe Costa; Carlo La Vecchia; Luisa Frova
Journal:  Int J Public Health       Date:  2018-07-26       Impact factor: 3.380

Review 2.  Regulation of HGF and c-MET Interaction in Normal Ovary and Ovarian Cancer.

Authors:  Youngjoo Kwon; Andrew K Godwin
Journal:  Reprod Sci       Date:  2016-09-27       Impact factor: 3.060

3.  Resibufogenin inhibits ovarian clear cell carcinoma (OCCC) growth in vivo, and migration of OCCC cells in vitro, by down-regulating the PI3K/AKT and actin cytoskeleton signaling pathways.

Authors:  Guannan Zhou; Zhongyi Zhu; Lihua Li; Jingxin Ding
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

4.  BCL2L1 is identified as a target of naringenin in regulating ovarian cancer progression.

Authors:  Jing Xu; Zhe Guo; Shuang Yuan; Heli Li
Journal:  Mol Cell Biochem       Date:  2022-02-19       Impact factor: 3.396

Review 5.  The expression of cancer-testis antigen in ovarian cancer and the development of immunotherapy.

Authors:  Jianhang Zhao; Zhaoxu Xu; Yan Liu; Xiaobin Wang; Xinli Liu; Yanan Gao; Ying Jin
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

6.  [TIM-3 gene is highly expressed in ephithelial ovarian cancer to promote proliferation and migration of ovarian cancer cells].

Authors:  Y Huo; Y Wang; N An; X DU
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-02-20

Review 7.  Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.

Authors:  Tova M Bergsten; Joanna E Burdette; Matthew Dean
Journal:  Cancer Lett       Date:  2020-02-15       Impact factor: 8.679

8.  MENOPAUSAL ANDROGEN EXCESS - ASSOCIATED CARDIO-METABOLIC RISK: CLUES FOR OVARIAN LEYDIG CELL TUMOUR (CASE REPORT AND MINI-REVIEW OF LITERATURE).

Authors:  A A Gheorghisan-Galateanu; D Terzea; A Valea; M Carsote
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jul-Sep       Impact factor: 0.877

9.  H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis.

Authors:  Yimin Ma; Wei Zheng
Journal:  J Ovarian Res       Date:  2021-06-09       Impact factor: 5.506

10.  Racial/Ethnic Differences in Ovarian Cancer Risk: Results from the Multiethnic Cohort Study.

Authors:  Danja Sarink; Anna H Wu; Loïc Le Marchand; Kami K White; Song-Yi Park; V Wendy Setiawan; Brenda Y Hernandez; Lynne R Wilkens; Melissa A Merritt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-07-30       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.